Detection of small hepatocellular carcinoma: Comparison of conventional gadolinium-enhanced MRI with gadoliniumenhanced MRI after the administration of ferucarbotran

British Journal of Radiology

Volumn 82, Issue 978, 2009, Pages 468-474

  Kim, Young Kon ^a   Kim, C S ^a   Han, Y M ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FERUCARBOTRAN; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SIZE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; THREE DIMENSIONAL IMAGING;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; IRON; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXIDES;

EID: 66749097904     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/76535286     Document Type: Article

References (30)

1. Ward J, Robinson PJ. How to detect hepatocellular carcinoma in cirrhosis. Eur Radiol 2002;12:2258-2272 (Pubitemid 36940322)
2. Runge VM, Kirsch JE, Thomas GS. High-dose applications of gadolinium chelates in magnetic resonance imaging. Magn Reson Med 1991;22:358-363
3. Runge VM, Pels Rijcken TH, Davidoff A, Wells JW, Stark DD. Contrast-enhanced MR imaging of the liver. J Magn Reson Imaging 1994;4:281-289.
4. Kim T, Murakami T, Takahashi S, Tsuda K, Tomoda K, Narumi Y, et al. Effects of injection rates of contrast material on arterial phase hepatic CT. AJR Am J Roentgenol 1998;171:429-432 (Pubitemid 28348125)
5. Awai K, Takada K, Onishi H, Hori S. Aortic and hepatic enhancement and tumor-to-liver contrast: analysis of the effect of different concentrations of contrast material at multi-detector row helical CT. Radiology 2002;224:757-763 (Pubitemid 34919809)
6. Hanninen EL, Vogl TJ, Felfe R, Pegios W, Balzer J, Clauss W, et al. Detection of focal liver lesions at biphasic spiral CT: randomized double-blind study of the effect of iodine concentration in contrast materials. Radiology 2000;216:403-409 (Pubitemid 30599857)
7. Ward J, Guthrie JA, Scott DJ, Atchley J, Wilson D, Davies MH, et al. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis. Radiology 2000;216:154-162 (Pubitemid 30434736)
8. Kim MJ, Kim JH, Chung JJ, Park MS, Lim JS, Oh YT. Focal hepatic lesions: detection and characterization with combination gadolinium- and superparamagnetic iron oxideenhanced MR imaging. Radiology 2003;228:719-726 (Pubitemid 37025482)
9. Bhartia B, Ward J, Guthrie JA, Robinson PJ. Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue. AJR Am J Roentgenol 2003;180:577-584 (Pubitemid 36237194)
10. Kim YK, Kwak HS, Han YM, Kim CS. Usefulness of combining sequentially acquired gadobenate dimeglumineenhanced magnetic resonance imaging and resovistenhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography. J Comput Assist Tomogr. 2007;31:702-711 (Pubitemid 47482489)
11. Semelka RC, Lee JK, Worawattanakul S, Noone TC, Patt RH, Ascher SM. Sequential use of ferumoxide particles and gadolinium chelate for the evaluation of focal liver lesions on MRI. J Magn Reson Imaging 1998;8:670-674 (Pubitemid 28267789)
12. Lencioni R, Pinto F, Armillotta N, Di Giulio M, Gaeta P, Di Candio G, et al. Intrahepatic metastatic nodules of hepatocellular carcinoma detected at Lipiodol CT: imaging-pathologic correlation. Abdominal imaging 1997;22:253-258 (Pubitemid 27183625)
13. Rofsky NM, Lee VS, Laub G, Pollack MA, Krinsky GA, Thomasson D, et al. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 1999;212:876-884 (Pubitemid 29410996)
14. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174 (Pubitemid 8054849)
15. Reimer P, Balzer T. Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast- enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol 2003;13:1266-1276 (Pubitemid 36790627)
16. Kim YK, Kim CS, Kwak HS, Lee JM. Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas comparison with superparamagnetic iron oxide-enhanced MR imaging. J Magn Reson Imaging 2004;20:826-837 (Pubitemid 39426079)
17. Ward J, Robinson PJ. Combined use of MR contrast agents for evaluating liver disease. Magn Reson Imaging Clin N Am 2001;9:767-802. (Pubitemid 33041950)
18. Jeong YY, Mitchell DG, Kamishima T. Small (<20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications. AJR Am J Roentgenol 2002;178:1327-1334 (Pubitemid 34547809)
19. Holland AE, Hecht EM, Hahn WY, Kim DC, Babb JS, Lee VS, et al. Importance of small (≤20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Radiology 2005;237:938-944 (Pubitemid 41636384)
20. Lutz AM, Willmann JK, Goepfert K, Marincek B, Weishaupt D. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging. Radiology 2005;237:520-528 (Pubitemid 41507889)
21. Yu JS, Kim KW, Jeong MG, Lee JT, Yoo HS. Nontumorous hepatic arterial-portal venous shunts: MR imaging findings. Radiology 2000;217:750-756
22. Lim JH, Choi D, Kim SH, Lee SJ, Lee WJ, Lim HK, et al. Detection of hepatocellular carcinoma: value of adding delayed-phase imaging to dual-phase helical CT. AJR Am J Roentgenol 2002;179:67-73. (Pubitemid 34694813)
23. Kim YK, Lee YH, Kim CS, Han YM. Added diagnostic value of T2-weighted MR imaging to gadolinium-enhanced threedimensional dynamic MR imaging for the detection of small hepatocellular carcinomas. Eur J Radiol 2008;67:304-310
24. Tang Y, Yamashita Y, Arakawa A, Namimoto T, Mitsuzaki K, Abe Y, et al. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium-and ferumoxides-enhanced MR imaging. AJR Am J Roentgenol. 1999;172:1547-1554 (Pubitemid 29242335)
25. Pauleit D, Textor J, Bachmann R, Conrad R, Flacke S, Layer G, et al. Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver. Radiology 2002;222:73-80. (Pubitemid 34031469)
26. Kim YK, Kim CS, Lee YH, Kwak HS, Lee JM. Comparison of superparamagnetic iron oxide-enhanced and gadobenate dimeglumine-enhanced dynamic MRI for detection of small hepatocellular carcinomas. AJR Am J Roentgenol 2004;182:1217-1223 (Pubitemid 38525517)
27. Matsuo M, Kanematsu M, Kondo H, Maeda S, Goshima S, Suenaga I, et al. Arterioportal shunts mimicking hepatic tumors with hyperintensity on T2-weighted MR images. J Magn Reson Imaging 2002;15:330-333 (Pubitemid 34195130)
28. Ngan H. Lipiodol computerized tomography: how sensitive and specific is the technique in the diagnosis of hepatocellular carcinoma? Br J Radiol 1990;63:771-775
29. Lee KH, Choi BI, Han JK, Jang HJ, Kim TK, Han MC. Nodular hepatocellular carcinoma: variation of tumor conspicuity on single-level dynamic scan and optimization of fixed delay times for two-phase helical CT. J Comput Assist Tomogr 2000;24:212-218 (Pubitemid 32206196)
30. Francis IR, Cohan RH, McNulty NJ, Platt JF, Korobkin M, Gebremariam A, et al. Multidetector CT of the liver and hepatic neoplasms: effect of Multiphasic imaging on tumor conspicuity and vascular enhancement. AJR Am J Roentgenol 2003;180:1217-1224 (Pubitemid 36504605)